Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07293117

Evaluating Heart & Soil's Lifeblood on Iron and Energy Levels

This study explores how Heart & Soil's Lifeblood impacts iron levels and energy.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

This remotely administered decentralized trial is designed to meticulously investigate the testimonials provided by individuals who have experienced changes in their iron levels and energy after using Heart & Soil's Lifeblood supplement. Recognizing the pivotal role of iron in red blood cell formation, oxygen transport, and numerous other physiological processes, this study aims to bridge the gap in current research concerning the effects of natural products, particularly freeze-dried organ extracts, on human biology. Unlike the extensively studied synthetic iron sulfate supplements, the study focuses on exploring the benefits of a natural alternative, aiming to enhance the understanding of how such products can support healthy iron stores and, by extension, improve overall vitality.

The objective of this study is to empower participants with personalized data and insights regarding their iron and energy levels. Through the evaluation of a comprehensive iron panel conducted before and after the supplementation of Lifeblood, investigators intend to establish a correlation between these iron levels and the perceptions of energy and fatigue, as reported through supplementary survey data. This approach transcends the realm of generic claims, delving into tangible, real-world outcomes that are directly influenced by participant engagement.

The specific aim is to quantify the impact of Lifeblood supplementation on iron levels and the subsequent enhancement of energy levels, thereby providing participants with personalized health insights. This will not only offer tailored feedback on how the supplement influences individual vitality but will also empower participants with the knowledge to make informed lifestyle decisions based on their unique health profiles.

The significance of this study lies in its potential to revolutionize the way individuals perceive and manage their energy levels through the consumption of natural, whole food, organ extracts. By integrating clinical studies with scientific rigor, investigators are set to validate the real-world experiences of individuals using supplementation to support their health. Although individual results may vary, the anticipated outcome is a personalized understanding of the role of iron in energy maintenance, presenting participants with a navigational tool for future wellness decisions. This study represents a pivotal step towards elevating our understanding of natural health products and their potential to enrich human health and vitality.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Can read and understand English.
  • US resident.
  • Willing and able to follow the requirements of the protocol.

Exclusion criteria

  • Individuals with Hemochromatosis
  • Individuals with Severe Allergies
  • Pregnant or Nursing Women
  • Individuals with Gastrointestinal Disorders
  • Individuals on Iron-Related Medications
  • Individuals with Mental Health Disorders
  • Competitive Athletes

Treatment and study plan

Heart & Soil Lifeblood

Dietary Supplement

Lifeblood is an iron and blood-supporting supplement made of liver, spleen, and whole blood extract.

Primary outcomes

  1. Fatigue Perception and Impact Survey

    Time frame: Change from baseline (Day 1-7) in fatigue perception and impact at 4 to 5 weeks after the start of the intervention

    The Fatigue Perception and Impact Survey (FPIS) is a specialized questionnaire developed to evaluate the presence, severity, and impact of fatigue on an individual's life. Comprising a series of questions, the survey aims to capture both the subjective experience of fatigue and its consequences across various domains, such as physical, emotional, and social aspects. This tool is commonly used in clinical settings to assess fatigue in patients with various medical conditions, including chronic illnesses and cancer, helping healthcare professionals better understand and address the debilitating effects of fatigue on patients' quality of life. Researchers also employ the FPIS to gather valuable data on fatigue patterns, enabling a deeper understanding of the condition and potential interventions to alleviate its impact.

  2. Iron and Ferritin Blood Levels

    Time frame: Change from baseline (Day 1-10) in iron and ferritin blood levels at 11 to 14 weeks after the start of the intervention

    Easily check your iron and ferritin levels at home with the MyLabsDirect test kit, featuring the Tasso specimen collection device. Simply clean your upper arm, apply the Tasso device, and press a button to painlessly collect a small blood sample in minutes. Secure your sample in the provided tube, package it, and mail it to MyLabsDirect's CLIA-certified lab for accurate results-no clinic visit required

Study contacts

Contact information is provided by the study sponsor or research team.

Matthew Amsden

CONTACT

[email protected]

646-679-2479

Sponsors and collaborators

Lead sponsor

Efforia, Inc

Industry

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 19, 2025
Registry last updated
Dec 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.